Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SELVAS AI is a leading South Korean artificial intelligence company specializing in human-machine interaction and digital healthcare solutions. The company's core healthcare offering, Selvy Checkup, is a deep learning-based platform that analyzes health examination data to predict the onset risk of major chronic diseases such as diabetes and heart disease. Another key product, Selvy MediVoice, utilizes advanced voice recognition technology to provide automated medical transcription, significantly reducing the documentation burden for clinicians. By integrating AI across voice, text, and data analysis, SELVAS AI aims to improve patient outcomes through early detection and streamlined clinical workflows.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SELVAS AI.